XLVIvsVHTETF Comparison
ETF 1
XLVI
State Street Health Care Select Sector SPDR Premium Income Fund
This fund is part of
Options Strategies
-0.49%
VS
State Street Health Care Select Sector SPDR Premium Income Fund (XLVI) belongs to the Options Strategies segment. Vanguard Health Care ETF (VHT) is part of the US Health Care segment. XLVI's top 2 sector exposures are Healthcare and Consumer Non-Cyclicals. In contrast, VHT's top sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. XLVI is more expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.09% for VHT. XLVI is up 5.69% year-to-date (YTD) with +$14M in YTD flows. VHT performs better with 8.91% YTD performance, and +$89M in YTD flows. Run a side-by-side ETF comparison of XLVI and VHT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
XLVI vs VHT performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/10/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XLVI VHT | -3.75%-1.78% | +3.97%+9.90% | +5.69%+8.91% | +16.54%+23.87% | n/a+33.75% | n/a+29.38% |
| Flows | XLVI VHT | +$4M+$73M | +$11M+$372M | +$14M+$89M | +$25M+$324M | --$2.17B | --$965M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XLVI VHT | +11.87%+18.20% | +11.09%+15.74% | n/a+14.66% | n/a+15.57% |
| Max drawdown | XLVI VHT | -4.77%-5.54% | -8.21%-10.39% | n/a-16.88% | n/a-17.77% |
| Max drawdown duration | XLVI VHT | 16d22d | 115d169d | n/a435d | n/a767d |
Trading data
XLVI | VHT | |
Last sale 9/11/2026 at 1:30 PM | $25.71 | $310.74 |
| Previous close 09/10/2026 | $25.73 | $311.27 |
| Consolidated volume 09/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
XLVI
is actively managed and doesn’t replicate an indexXLVI | VHT | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
XLVI | VHT | |
|---|---|---|
| Last price | $25.71 | $310.74 |
| 1D performance | -0.07% | -0.17% |
| AuM | $25.47 M | $18.81 B |
| E/R | 0.35% | 0.09% |
Characteristics
XLVI | VHT | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | State Street Investment Management | Vanguard |
| Benchmark | - | MSCI US IMI Health Care 25/50 Index |
| N° of holdings | 59 | 413 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | July 30, 2025 | January 26, 2004 |
| ESG | No | No |
Advertisement
Exposure
Countries
XLVI
USA
97.34%
Other
2.66%
VHT
USA
96.91%
Other
3.09%
Sectors
XLVI
Healthcare
97.32%
Other
2.68%
VHT
Healthcare
97.52%
Other
2.48%
Advertisement
Diversification
XLVI
Total weight of top 15 holdings out of 15
71.63%
VHT
Total weight of top 15 holdings out of 15
61.16%
Top 15 holdings
Data as of July 31, 2026
XLVI
Eli Lilly & Co.
15.45%
Johnson & Johnson
10.49%
AbbVie, Inc.
7.54%
UnitedHealth Group, Inc.
6.40%
Merck & Co., Inc.
5.47%
Thermo Fisher Scientific, Inc.
3.63%
Amgen, Inc.
3.53%
Abbott Laboratories
3.13%
Gilead Sciences, Inc.
2.75%
Pfizer Inc.
2.42%
Bristol Myers Squibb Co.
2.27%
CVS Health Corp.
2.27%
Intuitive Surgical, Inc.
2.13%
Danaher Corp.
2.09%
Vertex Pharmaceuticals, Inc.
2.06%
VHT
Eli Lilly & Co.
13.37%
Johnson & Johnson
8.83%
AbbVie, Inc.
6.43%
UnitedHealth Group, Inc.
5.45%
Merck & Co., Inc.
4.67%
Thermo Fisher Scientific, Inc.
3.09%
Amgen, Inc.
3.01%
Abbott Laboratories
2.67%
Gilead Sciences, Inc.
2.34%
Pfizer Inc.
2.06%
Bristol Myers Squibb Co.
1.93%
CVS Health Corp.
1.93%
Intuitive Surgical, Inc.
1.82%
Danaher Corp.
1.80%
Vertex Pharmaceuticals, Inc.
1.76%
Frequently asked questions about XLVI and VHT
How have the XLVI and VHT ETFs performed in 2026?
As of September 10, 2026, XLVI is up 5.69% year-to-date (YTD), while VHT has returned 8.91%. That puts VHT better performer ahead so far this year.
Which ETF is attracting more investor money: XLVI or VHT?
Year-to-date, the XLVI ETF saw +$14M in flows, compared to +$89M for VHT.
Which ETF is more volatile: XLVI or VHT?
Over the past year, XLVI had a volatility of 11.09%, while VHT experienced 15.74%.
Which ETF is bigger: XLVI or VHT?
As of September 10, 2026, XLVI holds $25.47 M in assets under management (AUM), while VHT manages $18.81 B.
What sectors do the XLVI and VHT ETFs invest in?
XLVI leans toward sectors like Healthcare. Meanwhile, VHT focuses on Healthcare.
What are the top holdings of the XLVI ETF and VHT ETF?
XLVI top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. VHT holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
Which ETF is more diversified: XLVI or VHT?
XLVI holds 59 securities with 71.63% of its assets in the top 15. VHT has 413 securities and a top 15 weight of 61.16%.
Advertisement
Latest news about XLVI & VHT
My Contrarian Equity ETF Picks For 2026
November 13, 2025
VHT
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
VHT
Health Care Sector Down After a Cyberattack on UnitedHealth
March 4, 2024
VHT
Advertisement
2024 Stock Market Predictions from Vanguard, BlackRock, & State Street: ETFs to Watch
January 5, 2024
VHT
Tony's ETF Buyer's Guide: Sector ETFs (Vanguard versus State Street SPDR)
December 1, 2023
VHT
Defensive investing: Utility and healthcare sector ETFs
November 30, 2022
VHT
Advertisement
